← Open Payments lookup

LAURA LAROSE: Open Payments

NPI 1538687462 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,883 in 31 payments from 11 companies in 2025. Trend: 2023 $2,477 · 2024 $3,432 · 2025 $1,883

Long term medical supply or device loan: $1,000Food & beverage: $803Education: $80
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation12$1,000
Janssen Biotech, Inc.2$217
AstraZeneca Pharmaceuticals LP3$212
Astellas Pharma US Inc1$130
Caris MPI, Inc.3$90
Celgene Corporation3$73
Gilead Sciences, Inc.2$49
Merck Sharp & Dohme LLC2$49
ARRAY BIOPHARMA INC1$28
Stemline Therapeutics Inc.1$20

Products named: KISQALI, RYBREVANT, Vyloy, MI CANCER SEEK, ERLEADA, REBLOZYL, Trodelvy, KEYTRUDA.

Industry payments across CA — which companies pay providers there.